HK22396A - Pharmaceutical composition containing felbinac - Google Patents

Pharmaceutical composition containing felbinac Download PDF

Info

Publication number
HK22396A
HK22396A HK22396A HK22396A HK22396A HK 22396 A HK22396 A HK 22396A HK 22396 A HK22396 A HK 22396A HK 22396 A HK22396 A HK 22396A HK 22396 A HK22396 A HK 22396A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
composition containing
composition
containing felbinac
felbinac
Prior art date
Application number
HK22396A
Other languages
English (en)
Inventor
Peter Ramsey Michael
William Saunders Richard
Original Assignee
Wyeth Holdings Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Holdings Corporation filed Critical Wyeth Holdings Corporation
Publication of HK22396A publication Critical patent/HK22396A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catching Or Destruction (AREA)
  • Fertilizers (AREA)
HK22396A 1991-10-01 1996-02-08 Pharmaceutical composition containing felbinac HK22396A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9120831A GB2260079B (en) 1991-10-01 1991-10-01 Pharmaceutical composition containing felbinac

Publications (1)

Publication Number Publication Date
HK22396A true HK22396A (en) 1996-02-16

Family

ID=10702242

Family Applications (1)

Application Number Title Priority Date Filing Date
HK22396A HK22396A (en) 1991-10-01 1996-02-08 Pharmaceutical composition containing felbinac

Country Status (22)

Country Link
EP (1) EP0535327B1 (cs)
JP (1) JP3268852B2 (cs)
KR (1) KR930007444A (cs)
CN (1) CN1042394C (cs)
AT (1) ATE144414T1 (cs)
AU (1) AU2609592A (cs)
CA (1) CA2079420A1 (cs)
CZ (1) CZ281758B6 (cs)
DE (1) DE69214768T2 (cs)
DK (1) DK0535327T3 (cs)
ES (1) ES2093747T3 (cs)
FI (1) FI106842B (cs)
GB (1) GB2260079B (cs)
GR (1) GR3021439T3 (cs)
HK (1) HK22396A (cs)
HU (2) HU217544B (cs)
IL (1) IL103288A (cs)
MX (1) MX9205389A (cs)
NO (1) NO300615B1 (cs)
NZ (1) NZ244470A (cs)
SK (1) SK279113B6 (cs)
ZA (1) ZA927531B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2007039825A2 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
CN1944378A (zh) * 2006-10-23 2007-04-11 广东中科药物研究有限公司 一种联苯乙酸氨丁三醇盐及其制备方法
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
AR073346A1 (es) * 2009-07-21 2010-11-03 Silva Pablo Cesar Composicion formadora de espuma para la generacion de senalizaciones de duracion temporal acotada
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
EP2544662B1 (en) 2010-03-10 2020-05-20 Nuvo Pharmaceuticals Inc. Foamable formulation
CN104262138B (zh) * 2014-08-22 2016-05-11 湖北美林药业有限公司 一种联苯乙酸化合物及其药物组合物
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN109568300A (zh) * 2018-12-11 2019-04-05 石家庄以岭药业股份有限公司 联苯乙酸或其盐在制备Xa抑制剂药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
US4847069A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
JPH07112984B2 (ja) * 1989-04-28 1995-12-06 久光製薬株式会社 泡状エアゾール製剤
CA2042583C (en) * 1989-07-28 1995-06-20 Akira Nakagawa Foamable aerosol preparation

Also Published As

Publication number Publication date
FI924392L (fi) 1993-04-02
DE69214768D1 (de) 1996-11-28
FI106842B (fi) 2001-04-30
ZA927531B (en) 1993-05-06
JP3268852B2 (ja) 2002-03-25
CA2079420A1 (en) 1993-04-02
HU9203112D0 (en) 1992-12-28
NZ244470A (en) 1993-08-26
EP0535327B1 (en) 1996-10-23
GB2260079A (en) 1993-04-07
IL103288A0 (en) 1993-02-21
KR930007444A (ko) 1993-05-20
CZ281758B6 (cs) 1997-01-15
HUT62470A (en) 1993-05-28
CZ271692A3 (en) 1993-04-14
HU217544B (hu) 2000-02-28
NO923809L (no) 1993-04-02
IL103288A (en) 1997-06-10
CN1073094A (zh) 1993-06-16
ES2093747T3 (es) 1997-01-01
SK279113B6 (sk) 1998-06-03
SK271692A3 (en) 1995-11-08
EP0535327A1 (en) 1993-04-07
AU2609592A (en) 1993-04-08
GB2260079B (en) 1995-08-09
FI924392A0 (fi) 1992-09-30
DK0535327T3 (da) 1996-11-18
ATE144414T1 (de) 1996-11-15
HU211697A9 (en) 1995-12-28
JPH05194208A (ja) 1993-08-03
DE69214768T2 (de) 1997-05-28
NO923809D0 (no) 1992-09-30
GR3021439T3 (en) 1997-01-31
CN1042394C (zh) 1999-03-10
MX9205389A (es) 1993-05-01
GB9120831D0 (en) 1991-11-13
NO300615B1 (no) 1997-06-30

Similar Documents

Publication Publication Date Title
HK22396A (en) Pharmaceutical composition containing felbinac
CA2264960A1 (en) External formulation containing loxoprofen
WO1996040086A3 (en) Compositions and methods for topical administration of pharmaceutically active agents
KR880009662A (ko) Igf-ii함유 약제
CA2095223A1 (en) Topical compositions for transdermal delivery of prodrug derivatives of morphine
CA2104474A1 (en) Compositions and methods for topical administration of pharmaceutically active agents
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
CA2077144A1 (en) Cosmetic Composition
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
CA2068763A1 (en) Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
CA2083404A1 (en) Therapeutically effective topical application of st1435
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
CA2170485A1 (en) Compositions Containing an Amino Acid Salt of Propionic Acid Non-Steroidal Anti-Inflammatory Agents and Caffeine
EP0249193A3 (en) Vehicle for topical application of pharmaceuticals
TW259711B (en) Pharmaceutical composition containing 4-biphenylacetic acid
CA2182812A1 (en) Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide
CA2179628A1 (en) Psoriasis Treatment
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
HK8994A (en) Medicament for treatment of pregnancy-induced hypertension
WO1998025596A3 (en) Use of a 6-aryl pyrimidine compound for treating multiple sclerosis
AU1305999A (en) (+)-ephedrine as a sympathomimetic drug
AU1778088A (en) Use of analgesic anti-inflammatory drugs in treating haemorrhoidal bleeding
CA2153570A1 (en) Pharmaceutical composition for treating nicotine dependence
CA2237335A1 (en) The use of cholinesterase inhibitors in the treatment of xerostomia

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20110930